Learn More
5528Background: Adding BEV to chemotherapy (cisplatin + P or topotecan + P) for advanced (a)CC significantly improved overall and progression-free survival (PFS) in the overall population in GOG240...
10072Background: Anthracyclines continue to rank among the most effective agents in Breast Cancer (BC) treatment, but its use is limited by a dose-dependent cardiotoxicity. Clinical studies have(More)
  • 1